Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business investor conference

Life Sciences Virtual Investor Forum Agenda

Analysis based on 12 articles · First reported Sep 14, 2026 · Last updated Sep 15, 2026

Sentiment
2
Attention
1
Articles
12
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The announcement is a routine investor-relations scheduling notice and is unlikely to move broad market indices or sector valuations on its own. Any price impact would be limited to the individual presenting micro- and small-cap life sciences names, and only if they disclose material pipeline or business updates during the September 17 sessions.

life sciences biotechnology pharmaceuticals

Virtual Investor Conferences, a proprietary investor conference series, announced on September 14, 2026 the agenda for its upcoming Life Sciences Virtual Investor Forum, scheduled for September 17, 2026 in New York. The online event is designed to connect individual investors, institutional investors, advisors, and analysts with clinical-stage and commercial life sciences companies. There is no admission fee for live presentations or for scheduling one-on-one meetings with company management. Greg Young, VP of Corporate Services at OTC Markets Group, said the forum gives these companies an efficient platform to share pipeline updates and engage directly with a global investor audience. The announced presentation lineup, with times in ET, is Avicanna Inc. at 10:30 AM, Sona Nanotech Inc. at 11:00 AM, Rafael Pharmaceuticals Inc. at 11:30 AM, Adaptimmune Therapeutics, Inc. at 1:00 PM, Amplia Therapeutics Ltd. at 2:00 PM, Altrova Health Inc. at 2:30 PM, CytoDyn Inc. at 3:30 PM, and 4DMedical Limited Ltd. at 4:00 PM. Attendees are encouraged to pre-register and run an online system check to expedite participation and receive event updates. The forum is a routine investor-relations engagement rather than a market-moving development, and no financial results, capital raises, or clinical data were disclosed in the announcement.

60 OTC Markets Group announced agenda
45 CytoDyn scheduled presentation
30 Avicanna scheduled presentation
30 Sona Nanotech scheduled presentation
30 Rafael Pharmaceuticals scheduled presentation
30 Adaptimmune Therapeutics scheduled presentation
30 Amplia Therapeutics scheduled presentation
30 Altrova Health scheduled presentation
30 4DMedical Limited scheduled presentation
exch
OTC Markets Group, through its Virtual Investor Conferences series, is the organizer and host of the forum and gains visibility as a venue connecting small-cap life sciences issuers with investors.
Importance 70.0 Sentiment 5.0
stock
Avicanna is scheduled to present at 10:30 AM ET, giving it a platform to update investors on its cannabinoid-based pipeline and strategy.
Importance 40.0 Sentiment 3.0
stock
Sona Nanotech is scheduled to present at 11:00 AM ET, offering investors an update on its nanotechnology-based diagnostics and therapeutics work.
Importance 40.0 Sentiment 3.0
priv
Rafael Pharmaceuticals is scheduled to present at 11:30 AM ET, providing a venue to discuss its pharmaceutical development pipeline.
Importance 40.0 Sentiment 3.0
priv
Adaptimmune Therapeutics is scheduled to present at 1:00 PM ET, giving the company an opportunity to outline recent developments to investors.
Importance 40.0 Sentiment 3.0
stock
Amplia Therapeutics is scheduled to present at 2:00 PM ET, allowing it to update investors on its clinical-stage programs.
Importance 40.0 Sentiment 3.0
priv
Altrova Health is scheduled to present at 2:30 PM ET, providing a platform to share its business strategy and pipeline updates.
Importance 40.0 Sentiment 3.0
stock
CytoDyn is scheduled to present at 3:30 PM ET, giving the company a chance to address investors on its development programs.
Importance 40.0 Sentiment 3.0
stock
4DMedical Limited is scheduled to present at 4:00 PM ET, closing the forum with an update on its medical imaging technology business.
Importance 40.0 Sentiment 3.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.